STAAR Surgical Company (STAA)


-1.49 (-4.61%)
Symbol STAA
Price $30.8
Beta 1.053
Volume Avg. 0.83M
Market Cap 1.504B
Shares () -
52 Week Range 30.78-81.81
1y Target Est -
DCF Unlevered STAA DCF ->
DCF Levered STAA LDCF ->
ROE 5.61% Neutral
ROA 4.18% Neutral
Operating Margin -
Debt / Equity 9.48% Neutral
P/E 81.05 Strong Buy
P/B 3.95 Strong Buy


Consensus EPS

Upgrades & Downgrades

Latest STAA news

Mr. Thomas G. Frinzi
Medical Instruments & Supplies
NASDAQ Global Market

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness. It also offers preloaded silicone cataract intraocular lenses and injector systems for use in cataract surgery. In addition, the company sells injector parts, and other related instruments and devices. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.